SLC26A3 and colorectal carcinoma: These findings demonstrate that SLC26A3 is reduced in CRC tissues, and downregulation of SLC26A3 expression is associated with CRC prognosis, metastasis, and differentiation, highlighting SLC26A3 as a potential target for intervention in CRC.